Genprex

Monthly Archives: July 2017

Genprex Files Registration Statement For Proposed Initial Public Offering

AUSTIN, TX, July 21, 2017 – Genprex, Inc. a clinical stage biopharmaceutical company, today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to the proposed initial public offering of its common stock.

Read More